Literature DB >> 25803369

Monitoring of International Diabetes Federation-recommended Clinical Diabetes Indicators in a Public Health Centre in Southwest Trinidad.

A S Dhanoo1,2, B N Cockburn2, N Shah3, R Superville1, F Hill-Briggs1,4.   

Abstract

OBJECTIVES: To examine availability of International Diabetes Federation (IDF)-recommended diabetes indicators in the medical charts of patients in active care at a public health centre in southwest Trinidad and Tobago, and to determine clinical status of the patient population according to Caribbean Health Research Council/Pan American Health Organization (CHRC/PAHO) guidelines for disease control.
METHODS: Data were extracted from the medical records of consecutive patients with diagnosed diabetes who presented for routine care at the health centre over a seven-month period. The three most recent dates and results for the following clinical indicators were extracted: glycated haemoglobin (HbA1c), blood pressure, lipid panel, random blood sugar and weight.
RESULTS: Data were extracted from 486 patient medical records (91% of patients who presented for care). The majority of records, 366 (76%), had one of three recommended IDF indicators of HbA1c, blood pressure or low-density lipoprotein (LDL) in the past year, 58 (12%) had two, 55 (11%) had three and seven (1%) had no indicators recorded. Random blood sugar and blood pressure were recorded in 93% of records, while only 20% had an HbA1c reported in the past year. The vast majority of patients did not meet guidelines for control of blood sugar, blood pressure or cholesterol. Due to a non-standardized HbA1c assay, rate of controlled HbA1c, based on CHRC/PAHO clinical guidelines, could not be determined.
CONCLUSIONS: Although availability of indicators suggests an increase from prior audits reported in the literature, current reporting patterns challenge optimal patient management and future systematic evaluation of trends in diabetes care and outcomes.

Entities:  

Year:  2014        PMID: 25803369      PMCID: PMC4663952          DOI: 10.7727/wimj.2014.026

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  6 in total

Review 1.  Errors in clinical laboratories or errors in laboratory medicine?

Authors:  Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

2.  Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations.

Authors:  A Finke; U Kobold; W Hoelzel; C Weykamp; K Miedema; J O Jeppsson
Journal:  Clin Chem Lab Med       Date:  1998-05       Impact factor: 3.694

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

4.  Changing patterns of primary care for diabetes in Trinidad and Tobago over 10 years.

Authors:  D Mahabir; M C Gulliford
Journal:  Diabet Med       Date:  2005-05       Impact factor: 4.359

5.  The cost of diabetes in Latin America and the Caribbean.

Authors:  Alberto Barceló; Cristian Aedo; Swapnil Rajpathak; Sylvia Robles
Journal:  Bull World Health Organ       Date:  2003-03-11       Impact factor: 9.408

6.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

  6 in total
  2 in total

1.  A Protocol for the Study of Polymorphisms and Response to Metformin in Patients with Type 2 Diabetes in Trinidad.

Authors:  Yuri Clement; Shamjeet Singh; Shastri Motilal; Rohan Maharaj; Marcella Nunez-Smith
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

2.  Prevalence of self-reported sleep duration and sleep habits in type 2 diabetes patients in South Trinidad.

Authors:  Rishi Ramtahal; Claude Khan; Kavita Maharaj-Khan; Sriram Nallamothu; Avery Hinds; Andrew Dhanoo; Hsin-Chieh Yeh; Felicia Hill-Briggs; Mariana Lazo
Journal:  J Epidemiol Glob Health       Date:  2015-06-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.